Literature DB >> 20733182

High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation.

Surena F Matin1, Ashish M Kamat, H Barton Grossman.   

Abstract

OBJECTIVE: We analyzed endoluminal ultrasonography (ELUS) for evaluating renal pelvic and ureteral, or upper tract, urothelial carcinoma (UTUC).
METHODS: Patients being treated for suspected UTUC underwent ureteroscopic evaluation immediately before ELUS, followed by ureteroscopic biopsy. Endoluminal ultrasonography was performed using mechanical radial scanning at 30 MHz in the B-mode using a 1.7-mm-diameter (5F) probe, which allows placement over a guide wire. Where possible, ELUS findings at the time of endoscopy were compared to the pathologic findings of resected specimens.
RESULTS: From July 2008 to March 2009, 15 patients underwent ELUS during ureteroscopic evaluation of suspected UTUC. No complications occurred as a result of ELUS. Ultrasonographic and endoscopic imaging findings from the evaluation of normal and abnormal anatomy were shown. Eleven patients had evaluable data. Seven patients underwent initial nephroureterectomy. Six of the 7 patients had accurate ELUS staging when correlated with the pathologic findings. The positive predictive value of ELUS was 66.7%, and the negative predictive value was 100%.
CONCLUSIONS: In this study, we showed the potential role of ELUS in improving the clinical staging accuracy of UTUC. Although the number of patients was too small to allow for definitive conclusions, these promising initial data suggest that, with additional experience, this modality can substantially improve the risk stratification of patients with UTUC.

Entities:  

Mesh:

Year:  2010        PMID: 20733182     DOI: 10.7863/jum.2010.29.9.1277

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  9 in total

1.  Urothelial carcinoma: Endoscopy to predict outcomes in upper tract urothelial cancer.

Authors:  Ramy F Youssef; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2012-04-03       Impact factor: 14.432

2.  Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Thomas Wimmer; Sebastien Monette; Simon Y Kimm; Majid Maybody; Stephen B Solomon; Jonathan A Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

Review 3.  Role of Narrow Band Imaging in Management of Urothelial Carcinoma.

Authors:  Emanuela Altobelli; Dimitar V Zlatev; Joseph C Liao
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

Review 4.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

Review 5.  The role of systemic chemotherapy in management of upper tract urothelial cancer.

Authors:  Bishoy A Gayed; Gregory R Thoreson; Vitaly Margulis
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

6.  Building bridges in urothelial carcinoma to face common challenges.

Authors:  Romain Mathieu; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

Review 7.  Why are upper tract urothelial carcinoma two different diseases?

Authors:  Tibor Szarvas; Orsolya Módos; András Horváth; Péter Nyirády
Journal:  Transl Androl Urol       Date:  2016-10

Review 8.  Upper urinary tract disease: what we know today and unmet needs.

Authors:  Romain Mathieu; Karim Bensalah; Ilaria Lucca; Aurélie Mbeutcha; Morgan Rouprêt; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2015-06

Review 9.  Neoadjuvant chemotherapy for upper tract urothelial carcinoma.

Authors:  Do Kyung Kim; Kang Su Cho
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.